Leila Pirhaji: The medical potential of AI and metabolites
Leila Pirhaji: Potensi medis Inteligensi Artifisial (AI) dan metabolit
Leila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases. Full bio
Double-click the English transcript below to play the video.
genom pada manusia,
to treat many diseases.
mengobati berbagai penyakit itu mudah.
could have a significant role
manusia juga memiliki peranan penting
of the population globally,
and leads to liver cancer
dan menjadi penyebab kanker hati
doesn't give us enough information
memberikan informasi
many other molecules in our body.
lain di dalam tubuh,
over 100,000 metabolites.
that is supersmall in their size.
berukuran sangat kecil.
fructose, fats, cholesterol --
fruktosa, lemak, kolesterol --
in our metabolism.
from both our genes as well as lifestyle.
informasi gen dan gaya hidup manusia.
to find treatments for many diseases.
untuk menemukan pengobatan
seorang dokter.
I left medical school,
meninggalkan
mempelajari obat-obatan.
algorithms to analyze biological data.
algoritma untuk menganalisis data biologi.
the metabolites in our body,
dari dalam tubuh,
how they are changed in a disease
untuk menguraikan perubahan data metabolit
changes to treat them.
tersebut untuk mengobati penyakit.
has done this before:
ada orang yang melakukan ini
di dalam tubuh.
we can measure their molecular mass
dapat diukur massa molekulernya
10 molecules with the exact same mass,
dengan massa yang persis sama,
identify all of them,
which could take decades
yang memakan waktu lama
intelligence, or AI, platform, to do that.
Artifisial atau platform AI
perkembangan data biologi
information about metabolites
informasi tentang metabolit
with other molecules.
as a meganetwork.
dalam jaringan besar.
jaringan atau darah pasien,
that are changed in a disease.
di dalam penyakit.
we don't know exactly what they are.
senyawa molekul yang pasti.
either the glucose, galactose or fructose.
adalah glukosa, galaktosa, atau fruktosa,
all these ambiguities.
semua ambiguitas itu.
are connected to each other
massa metabolit terhubung satu sama lain
what each metabolite mass is,
adalah glukosa
and other metabolites
dan metabolit lain
penyakit.
of disease mechanisms
mekanisme penyakit ini
effective therapeutics to target that.
terapeutik efektif sebagai pengobatan.
to bring this technology to the market
untuk membawa teknologi ini ke pasar
are working to discover
bekerja untuk menemukan
that metabolites are key drivers for,
yang disebabkan oleh metabolit,
by accumulation of fats,
of metabolites in the liver.
di dalam hati.
it's a huge epidemic with no treatment.
yang belum ditemukan obatnya.
is just one example.
sebuah contoh.
hundreds of other diseases
ratusan penyakit lain
data about metabolites
banyak data metabolit
how changes in metabolites
di dalam metabolit
smarter and smarter
for the right patients.
sesuai untuk pasien yang tepat.
menggunakan setiap baris kode.
ABOUT THE SPEAKER
Leila Pirhaji - Biotech entrepreneurLeila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases.
Why you should listen
Leila Pirhaji is the founder of ReviveMed, an AI platform that can quickly and inexpensively characterize large numbers of metabolites (small molecules like glucose or cholesterol) from the blood, urine and tissues of patients. This allows for the detection of molecular mechanisms that lead to disease and the discovery of drugs that target these disease mechanisms.
Leila Pirhaji | Speaker | TED.com